When it comes to investing, we’re often looking for a get-rich-quick kind of stock.
However, sometimes the stocks that will end up making you the most money are those that exhibit steady growth, instead of the rapid high highs and low lows.
Finding these stocks can be tricky, because you may not know what to look for.
But with my help, I’ll make sure you don’t miss out on the easiest profits of your life.
It’s always exciting to see where some of the really powerful, heavyweight stocks (like Amazon) started out, and where some of their low points were compared with where they stand today.
What you need to remember though, is that the people who got in at those low prices and ended up making huge profits had no way of knowing that was going to happen.
It’s not like there was some magic symbol that lit up letting people know Amazon would one day be worth $1,400/ share.
While it can be tempting to buy shares of a stock that have gone very low and then high, and then back again, those stocks are very risky and volatile.
It’s nearly impossible to predict where they will go, and you have to watch them very closely to know when to get out before you lose tons of money.
This is why I’d say you make easier money investing in a stock that is strong and steady, even if it doesn’t turn the kind of overnight profits you might be hoping for.
One such example I’m liking right now is Myriad Genetics (MYGN), a molecular diagnostic company.
MYGN is focused on developing and marketing innovative personalized medicine, predictive medicine, and prognostic medicine tests across the globe.
One such molecular diagnostic test is their myRisk Hereditary Cancer, which is a DNA sequencing test that searches for hereditary cancers in an individual.
MYGN has been a strong stock for the past year, not volatile, but steadily rising.
From August to October of last year the stock rose 58% in just under two months.
Then again in January, the stock jumped up 23% in less than a month.
While you may not see those immediate profits that you occasionally get lucky with if you expend a lot of time and effort analyzing charts and are willing to lose some money, MYGN is a stock that really takes care of itself.
Its growth has been steady and consistent, which means you won’t need to keep a constant eye on it.
On top of their steady growth this last year, there’s also been good news for MYGN this month.
The National Comprehensive Cancer Network updated its medical guidelines regarding prostate cancer treatment to include biomarker testing.
This will mean increased access to the exact testing MYGN is doing for cancer patients.
This announcement from the National Comprehensive Cancer Network also means that many of the testing conducted by MYGN, including myRisk Hereditary Cancer, will now be recommended to far more patients.
This is likely to contribute to more strength and bumps up in MYGN in the coming year.
MYGN certainly isn’t the sole company doing genetic testing for cancers, but they have been outperforming the broader industry for the past six months, and that’s looking to continue.
MYGN has been underestimated the last year, consistently beating earnings every single quarter by up to 29%.
So, consider getting into steady growth stocks like MYGN before everyone realizes this is a stock to be reckoned with, and make your own 58% profits without even having to think about it!
